Log in

Adding Fuel to the Fire: Infective Endocarditis and the Challenge of Cerebrovascular Complications

  • Stroke (DL Tirschwell, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Infective endocarditis is a deadly disease and made more deadly by neurologic complications. We review the cerebrovascular complications of infective endocarditis and focus our discussion on medical and surgical management.

Recent Findings

While management of stroke in the setting of infective endocarditis differs from standard stroke treatment, mechanical thrombectomy has proven safe and successful. Optimal timing of cardiac surgery in the setting of stroke remains an area of debate, but additional observational studies continue to add more detail to the discussion.

Summary

Cerebrovascular complications in the setting of infective endocarditis remain a high stakes clinical challenge. Timing of cardiac surgery in IE complicated by stroke exemplifies these dilemmas. While more studies have suggested that earlier cardiac surgery is likely safe for those with small ischemic infarcts, there remains a need for more data defining optimal timing of surgery in all forms of cerebrovascular involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Chen H, Zhan Y, Zhang K, Gao Y, Chen L, Zhan J, et al. The global, regional, and national burden and trends of infective endocarditis from 1990 to 2019: results from the global burden of disease study 2019. Front Med. 1990;2022:9. https://doi.org/10.3389/fmed.2022.774224.

    Article  Google Scholar 

  2. Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, et al. Challenges in infective endocarditis. J Am Coll Cardiol. 2017;69(3):325–44. https://doi.org/10.1016/j.jacc.2016.10.066.

    Article  PubMed  Google Scholar 

  3. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–86. https://doi.org/10.1161/CIR.0000000000000296.

    Article  CAS  PubMed  Google Scholar 

  4. Rudasill SE, Sanaiha Y, Mardock AL, Khoury H, **ng H, Antonios JW, et al. Clinical outcomes of infective endocarditis in injection drug users. J Am Coll Cardiol. 2019;73(5):559–70. https://doi.org/10.1016/j.jacc.2018.10.082.

    Article  PubMed  Google Scholar 

  5. Baddour LM, Weimer MB, Wurcel AG, McElhinney DB, Marks LR, Fanucchi LC, et al. Management of infective endocarditis in people who inject drugs: a scientific statement from the American Heart Association. Circulation. 2022;146(14):e187–201. https://doi.org/10.1161/CIR.0000000000001090.

    Article  PubMed  Google Scholar 

  6. García-Cabrera E, Fernández-Hidalgo N, Almirante B, Ivanova-Georgieva R, Noureddine M, Plata A, et al. Neurological complications of infective endocarditis. Circulation. 2013;127(23):2272–84. https://doi.org/10.1161/CIRCULATIONAHA.112.000813.

    Article  PubMed  Google Scholar 

  7. Thuny F, Avierinos J-F, Tribouilloy C, Giorgi R, Casalta J-P, Milandre L, et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J. 2007;28(9):1155–61. https://doi.org/10.1093/eurheartj/ehm005.

    Article  PubMed  Google Scholar 

  8. Nakatani S, Ohara T, Ashihara K, Izumi C, Iwanaga S, Eishi K, et al. JCS 2017 Guideline on prevention and treatment of infective endocarditis. Circ J. 2019;advpub. https://doi.org/10.1253/circj.CJ-19-0549.

  9. Saini V, Guada L, Yavagal DR. Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology. 2021;97(20 Supplement 2):S6–16. https://doi.org/10.1212/wnl.0000000000012781.

    Article  PubMed  Google Scholar 

  10. Debette S, Schilling S, Duperron MG, Larsson SC, Markus HS. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurol. 2019;76(1):81–94. https://doi.org/10.1001/jamaneurol.2018.3122.

    Article  PubMed  Google Scholar 

  11. Smith EE, Saposnik G, Biessels GJ, Doubal FN, Fornage M, Gorelick PB, et al. Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48(2):e44–71. https://doi.org/10.1161/str.0000000000000116.

    Article  PubMed  Google Scholar 

  12. Chen C-C, Wu VC-C, Chang C-H, Chen C-T, Hsieh P-C, Liu Z-H, et al. Long-term outcome of neurological complications after infective endocarditis. Sci Rep. 2020;10(1):3994. https://doi.org/10.1038/s41598-020-60995-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Sonneville R, Mirabel M, Hajage D, Tubach F, Vignon P, Perez P, et al. Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study. Crit Care Med. 2011;39(6):1474–81. https://doi.org/10.1097/CCM.0b013e3182120b41.

    Article  PubMed  Google Scholar 

  14. Cabell CH, Pond KK, Peterson GE, Durack DT, Corey GR, Anderson DJ, et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J. 2001;142(1):75–80. https://doi.org/10.1067/mhj.2001.115790.

    Article  CAS  PubMed  Google Scholar 

  15. Derex L, Bonnefoy E, Delahaye F. Impact of stroke on therapeutic decision making in infective endocarditis. J Neurol. 2010;257(3):315–21. https://doi.org/10.1007/s00415-009-5364-3.

    Article  PubMed  Google Scholar 

  16. Dickerman SA, Abrutyn E, Barsic B, Bouza E, Cecchi E, Moreno A, et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J. 2007;154(6):1086–94. https://doi.org/10.1016/j.ahj.2007.07.023.

    Article  CAS  PubMed  Google Scholar 

  17. Asaithambi G, Adil MM, Qureshi AI. Thrombolysis for ischemic stroke associated with infective endocarditis: results from the nationwide inpatient sample. Stroke. 2013;44(10):2917–9. https://doi.org/10.1161/strokeaha.113.001602.

    Article  PubMed  Google Scholar 

  18. • Feil K, Küpper C, Tiedt S, Dimitriadis K, Herzberg M, Dorn F, et al. Safety and efficacy of mechanical thrombectomy in infective endocarditis: a matched case–control analysis from the German Stroke Registry-Endovascular Treatment. Eur J Neurol. 2021;28(3):861–7. https://doi.org/10.1111/ene.14686. This study offered the largest series of patients published suggesting that mechanical thrombectomy is a therapeutic option for patients with infective endocarditis patients with stroke caused by large vessel occlusion.

    Article  PubMed  Google Scholar 

  19. Marnat G, Sibon I, Gory B, Richard S, Olindo S, Consoli A, et al. Safety and outcomes of mechanical thrombectomy for acute stroke related to infective endocarditis: a case-control study. Int J Stroke. 2021;16(5):585–92. https://doi.org/10.1177/1747493020925360.

    Article  PubMed  Google Scholar 

  20. Salaun E, Touil A, Hubert S, Casalta J-P, Gouriet F, Robinet-Borgomano E, et al. Intracranial haemorrhage in infective endocarditis. Arch Cardiovasc Dis. 2018;111(12):712–21. https://doi.org/10.1016/j.acvd.2018.03.009.

    Article  PubMed  Google Scholar 

  21. Hess A, Klein I, Iung B, Lavallée P, Ilic-Habensus E, Dornic Q, et al. Brain MRI findings in neurologically asymptomatic patients with infective endocarditis. AJNR Am J Neuroradiol. 2013;34(8):1579–84. https://doi.org/10.3174/ajnr.A3582.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hart RG, Kagan-Hallet K, Joerns SE. Mechanisms of intracranial hemorrhage in infective endocarditis. Stroke. 1987;18(6):1048–56. https://doi.org/10.1161/01.str.18.6.1048.

    Article  CAS  PubMed  Google Scholar 

  23. Murai R, Kaji S, Kitai T, Kim K, Ota M, Koyama T, et al. The clinical significance of cerebral microbleeds in infective endocarditis patients. Semin Thorac Cardiovasc Surg. 2019;31(1):51–8. https://doi.org/10.1053/j.semtcvs.2018.09.020.

    Article  PubMed  Google Scholar 

  24. Okazaki S, Sakaguchi M, Hyun B, Nagano K, Tagaya M, Sakata Y, et al. Cerebral microbleeds predict impending intracranial hemorrhage in infective endocarditis. Cerebrovasc Dis. 2011;32(5):483–8. https://doi.org/10.1159/000331475.

    Article  PubMed  Google Scholar 

  25. Alawieh A, Chaudry MI, Turner RD, Turk AS, Spiotta AM. Infectious intracranial aneurysms: a systematic review of epidemiology, management, and outcomes. J Neurointerv Surg. 2018;10(7):708–16. https://doi.org/10.1136/neurintsurg-2017-013603.

    Article  PubMed  Google Scholar 

  26. Wilson WR, Bower TC, Creager MA, Amin-Hanjani S, O’Gara PT, Lockhart PB, et al. Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association. Circulation. 2016;134(20):e412–60. https://doi.org/10.1161/CIR.0000000000000457.

    Article  PubMed  Google Scholar 

  27. Chambers HF, Bayer AS. Native-valve infective endocarditis. N Engl J Med. 2020;383(6):567–76. https://doi.org/10.1056/NEJMcp2000400.

    Article  PubMed  Google Scholar 

  28. Iversen K, Ihlemann N, Gill SU, Madsen T, Elming H, Jensen KT, et al. Partial oral versus intravenous antibiotic treatment of endocarditis. N Engl J Med. 2019;380(5):415–24. https://doi.org/10.1056/NEJMoa1808312.

    Article  CAS  PubMed  Google Scholar 

  29. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128. https://doi.org/10.1093/eurheartj/ehv319.

    Article  PubMed  Google Scholar 

  30. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72–227. https://doi.org/10.1161/CIR.0000000000000923.

    Article  PubMed  Google Scholar 

  31. Snygg-Martin U, Rasmussen RV, Hassager C, Bruun NE, Andersson R, Olaison L. Warfarin therapy and incidence of cerebrovascular complications in left-sided native valve endocarditis. Eur J Clin Microbiol Infect Dis. 2011;30(2):151–7. https://doi.org/10.1007/s10096-010-1063-3.

    Article  CAS  PubMed  Google Scholar 

  32. Yau JW, Lee P, Wilson A, Jenkins AJ. Prosthetic valve endocarditis: what is the evidence for anticoagulant therapy? Intern Med J. 2011;41(11):795–7. https://doi.org/10.1111/j.1445-5994.2011.02580.x.

    Article  CAS  PubMed  Google Scholar 

  33. Anavekar NS, Tleyjeh IM, Mirzoyev Z, Steckelberg JM, Haddad C, Khandaker MH, et al. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis. 2007;44(9):1180–6. https://doi.org/10.1086/513197.

    Article  PubMed  Google Scholar 

  34. Anavekar NS, Schultz JC, De Sa DD, Thomas JM, Lahr BD, Tleyjeh IM, et al. Modifiers of symptomatic embolic risk in infective endocarditis. Mayo Clin Proc. 2011;86(11):1068–74. https://doi.org/10.4065/mcp.2011.0111.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Chan KL, Dumesnil JG, Cujec B, Sanfilippo AJ, Jue J, Turek MA, et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol. 2003;42(5):775–80. https://doi.org/10.1016/s0735-1097(03)00829-5.

    Article  CAS  PubMed  Google Scholar 

  36. Monteleone PP, Shrestha NK, Jacob J, Gordon SM, Fraser TG, Rehm SJ, et al. Clinical utility of cerebral angiography in the preoperative assessment of endocarditis. Vasc Med. 2014;19(6):500–6. https://doi.org/10.1177/1358863X14557152.

    Article  PubMed  Google Scholar 

  37. Rice CJ, Cho SM, Marquardt RJ, Zhang LQ, Khoury J, Hardman J, et al. Clinical course of infectious intracranial aneurysm undergoing antibiotic treatment. J Neurol Sci. 2019;403:50–5. https://doi.org/10.1016/j.jns.2019.06.004.

    Article  PubMed  Google Scholar 

  38. Serrano F, Guédon A, Saint-Maurice JP, Labeyrie MA, Civelli V, Eliezer M, et al. Endovascular treatment of infectious intracranial aneurysms complicating infective endocarditis: a series of 31 patients with 55 aneurysms. Neuroradiology. 2022;64(2):353–60. https://doi.org/10.1007/s00234-021-02798-5.

    Article  PubMed  Google Scholar 

  39. Ragulojan R, Grupke S, Fraser JF. Systematic review of endovascular, surgical, and conservative options for infectious intracranial aneurysms and cardiac considerations. J Stroke Cerebrovasc Dis. 2019;28(3):838–44. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.11.035.

    Article  PubMed  Google Scholar 

  40. Shi H, Parikh NS, Esenwa C, Zampolin R, Shah H, Khasiyev F, et al. Neurological outcomes of patients with mycotic aneurysms in infective endocarditis. Neurohospitalist. 2021;11(1):5–11. https://doi.org/10.1177/1941874420931233.

    Article  PubMed  Google Scholar 

  41. Ducruet AF, Hickman ZL, Zacharia BE, Narula R, Grobelny BT, Gorski J, et al. Intracranial infectious aneurysms: a comprehensive review. Neurosurg Rev. 2010;33(1):37–46. https://doi.org/10.1007/s10143-009-0233-1.

    Article  PubMed  Google Scholar 

  42. John S, Walsh KM, Hui FK, Sundararajan S, Silverman S, Bain M. Dynamic angiographic nature of cerebral mycotic aneurysms in patients with infective endocarditis. Stroke. 2016;47(1):e8–10. https://doi.org/10.1161/STROKEAHA.115.011198.

    Article  PubMed  Google Scholar 

  43. Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Circulation. 2015;131(2):131–40. https://doi.org/10.1161/CIRCULATIONAHA.114.012461.

    Article  PubMed  Google Scholar 

  44. Ramos-Martínez A, Calderón-Parra J, Miró JM, Muñoz P, Rodríguez-Abella H, Valerio M, et al. Effect of the type of surgical indication on mortality in patients with infective endocarditis who are rejected for surgical intervention. Int J Cardiol. 2019;282:24–30. https://doi.org/10.1016/j.ijcard.2019.01.014.

    Article  PubMed  Google Scholar 

  45. Wang A, Gaca JG, Chu VH. Management considerations in infective endocarditis: a review. JAMA. 2018;320(1):72–83. https://doi.org/10.1001/jama.2018.7596.

    Article  PubMed  Google Scholar 

  46. Carino D, Fernández-Cisneros A, Hernández-Meneses M, Sandoval E, Llopis J, Falces C, et al. The fate of active left-side infective endocarditis with operative indication in absence of valve surgery. J Card Surg. 2020;35(11):3034–40. https://doi.org/10.1111/jocs.14967.

    Article  PubMed  Google Scholar 

  47. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110(6):1745–55. https://doi.org/10.1016/S0022-5223(95)70038-2.

    Article  CAS  PubMed  Google Scholar 

  48. Barsic B, Dickerman S, Kra**ovic V, Pappas P, Altclas J, Carosi G, et al. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis. 2013;56(2):209–17. https://doi.org/10.1093/cid/cis878.

    Article  PubMed  Google Scholar 

  49. Okita Y, Minakata K, Yasuno S, Uozumi R, Sato T, Ueshima K, et al. Optimal timing of surgery for active infective endocarditis with cerebral complications: a Japanese multicentre study. Eur J Cardiothorac Surg. 2016;50(2):374–82. https://doi.org/10.1093/ejcts/ezw035.

    Article  PubMed  Google Scholar 

  50. Yanagawa B, Pettersson GB, Habib G, Ruel M, Saposnik G, Latter DA, et al. Surgical management of infective endocarditis complicated by embolic stroke: practical recommendations for clinicians. Circulation. 2016;134(17):1280–92. https://doi.org/10.1161/CIRCULATIONAHA.116.024156.

    Article  PubMed  Google Scholar 

  51. Morita K, Sasabuchi Y, Matsui H, Fushimi K, Yasunaga H. Outcomes after early or late timing of surgery for infective endocarditis with ischaemic stroke: a retrospective cohort study. Interact Cardiovasc Thorac Surg. 2015;21(5):604–9. https://doi.org/10.1093/icvts/ivv235.

    Article  PubMed  Google Scholar 

  52. Piper C, Wiemer M, Schulte HD, Horstkotte D. Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis. 2001;10(6):703–11.

    CAS  PubMed  Google Scholar 

  53. Samura T, Yoshioka D, Toda K, Sakaniwa R, Yokoyama J, Suzuki K, et al. Emergency valve surgery improves clinical results in patients with infective endocarditis complicated with acute cerebral infarction: analysis using propensity score matching†. Eur J Cardiothorac Surg. 2019;56(5):942–9. https://doi.org/10.1093/ejcts/ezz100.

    Article  PubMed  Google Scholar 

  54. Kim YK, Choi CG, Jung J, Yu SN, Lee JY, Chong YP, et al. Effect of cerebral embolus size on the timing of cardiac surgery for infective endocarditis in patients with neurological complications. Eur J Clin Microbiol Infect Dis. 2018;37(3):545–53. https://doi.org/10.1007/s10096-017-3148-8.

    Article  PubMed  Google Scholar 

  55. Tam DY, Yanagawa B, Verma S, Ruel M, Fremes SE, Mazine A, et al. Early vs late surgery for patients with endocarditis and neurological injury: a systematic review and meta-analysis. Can J Cardiol. 2018;34(9):1185–99. https://doi.org/10.1016/j.cjca.2018.05.010.

    Article  PubMed  Google Scholar 

  56. • Musleh R, Schlattmann P, Caldonazo T, Kirov H, Witte OW, Doenst T, et al. Surgical timing in patients with infective endocarditis and with intracranial hemorrhage: a systematic review and meta-analysis. J Am Heart Assoc. 2022;11(10):e024401. https://doi.org/10.1161/JAHA.121.024401. Findings from this study, while limited by being based upon observational trials, offer the first and only meta-analysis published focused on optimal timing of cardiac surgery in infective endocarditis complicated by intracerebral hemorrhage.

  57. Pettersson GB, Hussain ST. Current AATS guidelines on surgical treatment of infective endocarditis. Ann Cardiothorac Surg. 2019;8(6):630–44. https://doi.org/10.21037/acs.2019.10.05.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Murai R, Funakoshi S, Kaji S, Kitai T, Kim K, Koyama T, et al. Outcomes of early surgery for infective endocarditis with moderate cerebral complications. J Thorac Cardiovasc Surg. 2017;153(4):831-40.e8. https://doi.org/10.1016/j.jtcvs.2016.10.074.

    Article  PubMed  Google Scholar 

  59. Oh TH, Wang TK, Pemberton JA, Raudkivi PJ. Early or late surgery for endocarditis with neurological complications. Asian Cardiovasc Thorac Ann. 2016;24(5):435–40. https://doi.org/10.1177/0218492316646903.

    Article  PubMed  Google Scholar 

  60. Ruttmann E, Abfalterer H, Wagner J, Grimm M, Müller L, Bates K, et al. Endocarditis-related stroke is not a contraindication for early cardiac surgery: an investigation among 440 patients with left-sided endocarditis. Eur J Cardiothorac Surg. 2020;58(6):1161–7. https://doi.org/10.1093/ejcts/ezaa239.

    Article  PubMed  Google Scholar 

  61. Zhang LQ, Cho SM, Rice CJ, Khoury J, Marquardt RJ, Buletko AB, et al. Valve surgery for infective endocarditis complicated by stroke: surgical timing and perioperative neurological complications. Eur J Neurol. 2020;27(12):2430–8. https://doi.org/10.1111/ene.14438.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arielle P. Davis.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 21 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharma, M., Davis, A.P. Adding Fuel to the Fire: Infective Endocarditis and the Challenge of Cerebrovascular Complications. Curr Cardiol Rep 25, 349–356 (2023). https://doi.org/10.1007/s11886-023-01856-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-023-01856-z

Keywords

Navigation